Highest-materiality recent filing
Ryan Specialty boosts buyback authorization by $300M to $600M total
Board increased share repurchase program by $300M on May 21, 2026; total authorization now $600M.
All six director nominees elected; David P. Bolger received ~1.23B for, ~2.91M against.
Ryan Specialty Q1 revenue up 15.2%; net income $40.6M vs prior-year loss
Total revenue $795.2M (+15.2% YoY); organic growth 11.8%, down from 12.9% prior-year.
Ryan Specialty enters option settlement for up to $52.3M share repurchases
Trust to sell up to ~$52.3M of Class A common stock to company at May 4 closing price.
Ryan Specialty sets 2026 annual meeting for April 28; record date March 2
Annual meeting date: April 28, 2026; held virtually.
Q4 revenue $751.2M (+13.2% YoY); organic growth 6.6% vs 11.0% prior year.
Board member Bobby Le Blanc to retire Feb. 11, 2026 after Onex sells stake
Robert Le Blanc, Onex CEO, retires from Ryan Specialty Board effective February 11, 2026; mutual agreement.
Ryan Specialty Q3 revenue up 24.8% to $754.6M, organic +15.0%, net income $62.6M
Total revenue $754.6M, +24.8% YoY; organic growth 15.0% (vs 11.8% prior-year).
Ryan Specialty appoints Keogh and Mulshine as Co-Presidents; Bickham advisor
Stephen P. Keogh named Co-President and COO; Brendan M. Mulshine named Co-President and CRO.
Ryan Specialty elects Michael G. Bungert to board; former Aon Re Chairman
Michael G. Bungert joined board effective Sept 3, 2025; assigned to Compensation and Governance Committee.
Ryan Specialty Q2 total revenue $855.2M, +23% YoY; Adj. EPS $0.66, +13.8%; declares $0.12 dividend
Total revenue $855.2M (+23.0% YoY); organic revenue growth 7.1% decelerated from 14.2%.
Ryan Specialty board lead director Cam Findlay dies; successors named
D. Cameron Findlay, board member since 2012 and Lead Director, passed away unexpectedly in July 2025.
Ryan Specialty stockholders approve governance overhaul including Class B vote sunset by Sept 2029
Stockholders approved declassification of Board and phase-in of annual director elections; four nominees elected to three-year terms expiring 2028.
Ryan Specialty Q1 rev up 25% to $690M; GAAP net loss $4.4M; declares $0.12 dividend
Total revenue $690.2M (+25% YoY); organic growth 12.9%.
Ryan Specialty appoints Steve Keogh as COO effective May 1, 2025
Keogh was Senior Advisor to Aon's Office of President and formerly President of Aon's Commercial Risk Solutions.
Ryan Specialty Q4 revenue up 24.5% to $663.5M; Adj. EBITDAC +36.2%; declares $0.12 dividend
Total revenue $663.5M (+24.5% YoY); organic growth 11.0% (vs 16.5% prior year).
Ryan Specialty Issues $600 Million Additional 5.875% Senior Secured Notes Due 2032
Issued $600M aggregate principal amount of additional 5.875% Senior Secured Notes due 2032 on Dec 9, 2024.
Ryan Specialty launches $500M add-on to 5.875% senior secured notes due 2032
Up to $500M aggregate principal of additional 5.875% senior secured notes due 2032 in a private offering.
Ryan Specialty upsizes and prices $600M of 5.875% senior secured notes due 2032
Offering increased by $100M from previously announced $500M; priced at 99.5% of par.
Ryan Specialty Q3 revenue up 20.5% to $604.7M; adj. EPS $0.41 beats prior year by 28%
Total revenue $604.7M (+20.5% YoY); organic revenue growth 11.8% (vs 15.0% prior year).
Ryan Specialty refinances $1.588B term loan, issues $600M 5.875% notes due 2032
Refinanced existing $1.5881B term loan; added $111.875M incremental term loan at SOFR+2.25% (down 50 bps).
Ryan Specialty proposes $500M senior secured notes offering; plans $1.7B term loan refinancing
Ryan Specialty, LLC offers $500M senior secured notes due 2032 to repay revolving credit borrowings used for US Assure acquisition.
Ryan Specialty upsizes and prices $600M Senior Secured Notes at 5.875% due 2032
Priced $600M aggregate principal of 5.875% Senior Secured Notes due 2032 at 100% of par.
Ryan Specialty completes acquisition of US Assure for $1.075B cash plus up to $400M earnout
Acquisition closed Aug 30 for $1.075B cash plus up to $400M earnout based on performance targets.
Ryan Specialty Q2 revenue $695M (+18.8%), acquires US Assure, CEO succession
Revenue $695.4M (+18.8% YoY); organic growth 14.2%; Net income $118M ($0.37 diluted EPS).
Ryan Specialty to acquire US Assure for ~$1.075B plus up to $400M earnout
Acquisition of US Assure for $1.075B in cash plus up to $400M earnout based on 3-year performance targets.
Founder/Chairman/CEO Pat Ryan (age 87) transitions to Executive Chairman, continuing as executive officer.
Elected Patrick G. Ryan, Michelle L. Collins, D. Cameron Findlay, John W. Rogers, Jr. to Board through 2027.
Ryan Specialty Q1 revenue $552M (+20.6% YoY); adj. EPS $0.35 (+34.6%)
Total revenue $552.0M, up 20.6% YoY; organic revenue growth 13.7% vs. 13.4% prior year.
Ryan Specialty Q4 revenue $532.9M (+22.5% YoY); initiates $0.11 quarterly dividend
Total revenue $532.9M (+22.5% YoY); organic revenue growth 16.0% (vs 10.3% prior year).
Ryan Specialty reprices $1.65B term loan, cuts rate 25 bps to SOFR+2.75%, saves ~$5.6M/yr
Term loan interest rate reduced from SOFR+3.00% to SOFR+2.75%; credit spread adjustment eliminated.
Ryan Specialty board changes: Devers retires; Pat Ryan Jr. appointed
William J. Devers retired from board effective Dec 31, 2023 after 11 years; no disagreement.
Ryan Specialty Q3 revenue up 21.8% to $502M; adj. diluted EPS $0.32 beats prior year
Total revenue $501.9M, up 21.8% YoY; organic growth rate 14.7%.
Ryan Specialty adds former Munich Re US CEO Anthony Kuczinski to Board
Anthony J. Kuczinski elected to Board, serves on Compensation & Governance Committee, effective Oct 30, 2023.
Ryan Specialty reports Q2 2023 revenue up 19.1% to $585.1M; adjusted diluted EPS $0.45
Revenue $585.1M, +19.1% YoY; organic growth 16.1% (prior-year 22.3%).
Ryan Specialty appoints Francesca Cornelli, Kellogg Dean, to Board of Directors
Francesca Cornelli, Dean of Northwestern's Kellogg School, appointed to board effective July 31, 2023.
Selling shareholders to sell 9M shares of Ryan Specialty at $43.45 in secondary offering
9,000,000 shares sold by selling shareholders at $43.45/share; company receives no proceeds.
David P. Bolger, Nicholas D. Cortezi, and Robert Le Blanc elected directors with over 1.245 billion votes each.
Ryan Specialty Q1 revenue up 18.3% to $457.6M; net income doubles to $36.5M
Total revenue $457.6M (+18.3% YoY); organic growth 12.9%.
Ryan Specialty Promotes Michael VanAcker to EVP of RT Specialty
Michael T. VanAcker moves from Chief Operating Officer to Executive Vice President of RT Specialty, effective March 9, 2023.
Board approved two-year restructuring program starting Q1 2023, expected to generate $35M annual cost savings by 2025.
Ryan Specialty sets 2023 annual meeting for May 1; record date March 10, proposal deadline March 6
Annual meeting of stockholders scheduled for May 1, 2023, held virtually.
Ryan Specialty Q3 2022 earnings reported; confidence low due to missing exhibit details
Q3 2022 earnings press release issued on Nov 10, 2022, but Exhibit 99.1 not included in filing text.
Ryan Specialty Q2 revenue up 26% to $491M; organic growth 22.3%
Net income $70.1M ($0.22 diluted EPS); adjusted net income $106.4M ($0.39 adjusted EPS).
Directors Bienen, Devers, O'Halleran, and Turner elected with over 97% of votes cast.
Ryan Specialty changes corporate name to Ryan Specialty Holdings, Inc. effective June 6, 2022
Name changed from Ryan Specialty Group Holdings, Inc. to Ryan Specialty Holdings, Inc.
Ryan Specialty Q1 revenue up 24.2% to $386.9M; organic growth 20.1%
Net income of $18.1M ($0.06 diluted EPS) vs net loss of $3.8M a year ago.
Ryan Specialty Q4 total revenue $378.5M (+15.8%), net income $29.6M, adj. EPS $0.29
Total revenue $378.5M (+15.8% YoY); organic revenue growth 15.4%.
Ryan Specialty Group adopts Executive Severance Plan for named executive officers
Severance plan covers named executive officers; effective Dec 31, 2021.
Ryan Specialty Group sets virtual 2022 annual meeting for June 7
Annual meeting to be held virtually on Tuesday, June 7, 2022.
On March 27, 2025, Ryan Specialty Holdings, Inc. (the “Company”) announced the appointment of Mr. Stephen P. Keogh to the position of Chief Operating Officer of the Company, effective May 1, 2025.
and Janice M. Hamilton, Chief Accounting Officer, as Chief Financial Officer
Patrick G. Ryan, the Company’s Founder, Chairman, and Chief Executive Officer, will transition to the role of Executive Chairman
The succession plan also includes the appointment of Jeremiah R. Bickham, Chief Financial Officer, as President
Timothy W. Turner, President of Ryan Specialty and Chairman and CEO of Ryan Turner Specialty (“RT Specialty”), will become Chief Executive Officer
On December 28, 2023, William J. Devers informed the Board of Directors (the “Board”) of Ryan Specialty Holdings, Inc. (the “Company”) that he has decided to retire from service on the Board effective as of December 31, 2023.
On December 29, 2023, the Board elected Patrick G. Ryan, Jr. as a director, effective January 1, 2024.
elected Anthony J. Kuczinski as a director and assigned him to its Compensation and Governance Committee, effective immediately.
On July 31, 2023, the Board of Directors (the “Board”) of Ryan Specialty Holdings, Inc. (the “Company”), upon the recommendation of the Compensation and Governance Committee of the Board, elected Francesca Cornelli as a director and assigned her to its Audit Committee, effective immediately.
On March 9, 2023, Ryan Specialty Holdings, Inc. (the “Company”) announced that Michael T. VanAcker is moving from his position as Chief Operating Officer to Executive Vice President of RT Specialty, Ryan Specialty’s wholesale brokerage and binding authority specialty.
On July 21, 2021, Henry S. Bienen, David P. Bolger, Michelle L. Collins, Nicholas D. Cortezi, William J. Devers, D. Cameron Findlay, Robert Le Blanc, Andrew J. McKenna, Michael D. O’Halleran, John W. Rogers, Jr. and Timothy W. Turner were appointed to the Company’s board of directors.
On July 21, 2021, Henry S. Bienen, David P. Bolger, Michelle L. Collins, Nicholas D. Cortezi, William J. Devers, D. Cameron Findlay, Robert Le Blanc, Andrew J. McKenna, Michael D. O’Halleran, John W. Rogers, Jr. and Timothy W. Turner were appointed to the Company’s board of directors.
Max materiality 0.90 · Median 0.65 · Most common event earnings